Achieving an adequate sample size can be a challenge for research in many rare diseases. The solution will differ for each study and depends on the research question. Some options may include leveraging existing patient networks or cohorts or considering a cluster trial design, if feasible.
Does PCORI have suggestions for how to facilitate studies given the smaller patient populations for rare diseases?
Have more questions? Submit a request